Paid Clinical Trials in Irving, TX
As of September 2026, 115 paid clinical trials are recruiting in Irving, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Irving offers studies at sites including NEXT Dallas for conditions such as Advanced Solid Tumors, Colorectal Cancer, Advanced Solid Tumor, Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Irving
Trials by drug in Irving
Filter results
Newly added in Irving
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
110 clinical trials
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
A Study of PHST001 in Advanced Solid Tumors
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Top Research Study Locations in Irving
Researchers run research studies in Irving, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| NEXT Dallas | Advanced Solid Tumors, Colorectal Cancer, Cancer | 19 |
| NEXT Oncology Dallas | Colorectal Cancer, Mesothelioma, Pancreatic Ductal Adenocarcinoma | 13 |
| NEXT Oncology | Advanced-stage Solid Tumors, Cancer, Cervical Adenocarcinoma | 11 |
| US Oncology Investigational Products Center (IPC) | Colorectal Neoplasms, Non-Small Cell Lung Cancer, Advanced Non-Small Cell Lung Cancer | 9 |
| NEXT Oncology - Dallas | Advanced Solid Tumors, CNS Tumor, CRC | 8 |
| US Oncology Investigational Product Center (IPC) | Advanced/Metastatic Urothelial Cancer, Breast Cancer, Cancer of the Prostate | 7 |
| US Oncology Investigational Products Center | Advanced Non-Small Cell Lung Cancer, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 4 |
| Texas Center for Proton Therapy | Cancer, Neoplasms, Pediatric Patients Treated With Radiation Therapy | 3 |
| GSK Investigational Site | Influenza, Human, Non-alcoholic Fatty Liver Disease | 2 |
| NEXT Dallas - Oncology Department | Advanced/Metastatic Colorectal Adenocarcinoma, MTAP-deleted Solid Tumors | 2 |
| Seaport Investigator Site | Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress | 2 |
| US Oncology Research Investigational Products Center | Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer | 2 |
| 015 | Advanced Solid Tumor | 1 |
| AARA Clinical Research - Lone Star Arthritis and Rheumatology Associates - Irving | Radiographic Axial Spondyloarthritis | 1 |
| AARA Clinical Research Lone Star Arthritis and Rheumatology | Arthritis, Psoriatic | 1 |
| ALS Global | Atopic Dermatitis, Eczema, Eczema Atopic Dermatitis | 1 |
| Artiva Investigational | IIM, Idiopathic Inflammatory Myopathies (IIMs), Myositis | 1 |
| Avenzo Therapeutics Recruiting Site | Locally Advanced, Metastatic Solid Tumors, Solid Tumor Cancer | 1 |
| Baylor - Christus Children's - Main Hospital | Failed or Difficult Intubation, Sequela, Intubation Complication, Intubation; Difficult | 1 |
| Crinetics Study Site | Neuroendocrine Neoplasm, Neuroendocrine Tumors, SST2-positive Neuroendocrine Neoplasms | 1 |
| DM Clinical Research - Irving | Heart Failure | 1 |
| Ep0247 21013 | Rett Syndrome | 1 |
| Exelixis Clinical | Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer (CRC), Drug-Drug Interaction (DDI) | 1 |
| Local Institution - 0017 | Schizophrenia | 1 |
| Local Institution - 007-999 | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
Active & Upcoming Studies in Irving (2026)
Recruiting trials in Irving grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (56 active studies)
- Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic · Phase 1 · Sutro Biopharma, Inc.
- Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer. · Phase 1 · ArriVent BioPharma, Inc.
Mental health & behavior (3 active studies)
- ALTO-207 in Adults With Treatment-resistant Depression (TRD) · Phase 2 · Alto Neuroscience
- Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT) · Bristol-Myers Squibb
Diabetes & metabolic (3 active studies)
- A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
- A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH · Phase 3 · GlaxoSmithKline
Vaccines (1 active study)
- A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age · Phase 3 · GlaxoSmithKline
Neurology & pain (1 active study)
- A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Cardiovascular (1 active study)
Pediatric (1 active study)
- Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy · Massachusetts General Hospital
Common conditions studied in Irving
- Advanced Solid Tumors (10 active studies)
- Colorectal Cancer (8 active studies)
- Advanced Solid Tumor (7 active studies)
- Breast Cancer (5 active studies)
- Non-Small Cell Lung Cancer (5 active studies)
- Solid Tumor (5 active studies)
Leading research sponsors in Irving
- Pfizer
- AstraZeneca
- Amgen
- Revolution Medicines, Inc.
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Irving?
There are approximately 115 recruiting clinical trials in Irving, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Irving pay participants?
Most recruiting trials in Irving compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Irving?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Irving?
The most common conditions under active study in Irving include Advanced Solid Tumors (10), Colorectal Cancer (8), Advanced Solid Tumor (7), Breast Cancer (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Irving?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Irving on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Irving?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Irving?
Recruiting research sites in Irving include NEXT Dallas, NEXT Oncology Dallas, NEXT Oncology, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Irving right now?
The largest active categories in Irving are Cancer & tumors (56), Mental health & behavior (3), Diabetes & metabolic (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.